1 entry found
Sort by: Latest |Relevance
15 Apr 2013 description
report The Guardian

In the constant fight between microbes and people, attempts to rein in the malarial parasite have just taken an interesting turn. On Thursday the founder of Amyris Biotech triumphantly announced production of 70m doses of the anti-malarial compound artemisinin. This sounds like good news for poor people but may be a step backwards – the start of a new hi-tech assault on farmers.

Read the full article